おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Asterion
company
About
Asterion develops patient-friendly drugs for the treatment of serious chronic and acute disorders.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $678K
- Industries
- Biotechnology
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Asterion is to design and develop superior, patient-friendly drugs for the treatment of serious chronic and acute disorders. Their patented technologies and products offer the promise of long-acting potent biopharmaceuticals that will require less frequent administration than existing marketed drugs. These products have the potential to improve healthcare outcomes and offer other potential benefits in terms of efficacy, side effect profile, compliance and manufacture.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$678K
Asterion has raised a total of
$678K
in funding over 2 rounds. Their latest funding was raised on
May 15, 2006 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 15, 2006 | Series Unknown | $678K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Asterion is funded by 1 investors.
Spirit Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Spirit Capital Partners
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
